BofA analyst Michael Ryskin lowered the firm’s price target on Align Technology (ALGN) to $185 from $200 and keeps an Underperform rating on the shares. Heading into Q1 earnings, the firm trimmed volume expectations for Align given persistent end-market weakness, but took average selling prices higher to reflect reduced foreign exchange headwinds.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALGN:
- Align Technology price target lowered to $249 from $272 at Morgan Stanley
- GOOGL, ON, ALGN: Morningstar (MORN) Names Top-Rated Stocks That Are Undervalued
- Align Technology announces commercial availability of Invisalign with mandibula
- Align Technology price target lowered to $250 from $295 at Mizuho
- Positive Outlook for Align Technology Amidst Stabilizing Market Share and Competitive Pressures